Atomistry » Fluorine » PDB 6zqs-7adg » 6zv8
Atomistry »
  Fluorine »
    PDB 6zqs-7adg »
      6zv8 »

Fluorine in PDB 6zv8: Crystal Structure of Thrombin in Complex with COMPOUND51

Enzymatic activity of Crystal Structure of Thrombin in Complex with COMPOUND51

All present enzymatic activity of Crystal Structure of Thrombin in Complex with COMPOUND51:
3.4.21.5;

Protein crystallography data

The structure of Crystal Structure of Thrombin in Complex with COMPOUND51, PDB code: 6zv8 was solved by M.Schafer, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 70.22 / 1.70
Space group C 1 2 1
Cell size a, b, c (Å), α, β, γ (°) 69.166, 70.342, 71.372, 90.00, 100.28, 90.00
R / Rfree (%) 20.3 / 24.7

Other elements in 6zv8:

The structure of Crystal Structure of Thrombin in Complex with COMPOUND51 also contains other interesting chemical elements:

Chlorine (Cl) 1 atom

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Crystal Structure of Thrombin in Complex with COMPOUND51 (pdb code 6zv8). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Crystal Structure of Thrombin in Complex with COMPOUND51, PDB code: 6zv8:

Fluorine binding site 1 out of 1 in 6zv8

Go back to Fluorine Binding Sites List in 6zv8
Fluorine binding site 1 out of 1 in the Crystal Structure of Thrombin in Complex with COMPOUND51


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Crystal Structure of Thrombin in Complex with COMPOUND51 within 5.0Å range:
probe atom residue distance (Å) B Occ
H:F1001

b:15.6
occ:1.00
F24 H:QQT1001 0.0 15.6 1.0
C23 H:QQT1001 1.4 14.9 1.0
C13 H:QQT1001 2.6 13.3 1.0
O H:HOH1138 2.8 28.5 1.0
N12 H:QQT1001 2.9 15.1 1.0
O H:CYS191 2.9 13.7 1.0
N H:GLY193 3.0 11.8 1.0
CA H:GLU192 3.1 17.1 1.0
OG H:SER195 3.1 19.1 1.0
N H:SER195 3.1 9.5 1.0
C H:CYS191 3.1 14.4 1.0
N H:ASP194 3.2 10.3 1.0
N H:GLU192 3.3 14.0 1.0
C H:GLU192 3.4 14.9 1.0
C14 H:QQT1001 3.8 12.7 1.0
CB H:SER195 3.9 14.0 1.0
C H:ASP194 3.9 9.8 1.0
CA H:ASP194 3.9 10.0 1.0
CA H:SER195 4.0 10.9 1.0
C10 H:QQT1001 4.0 14.4 1.0
CA H:GLY193 4.0 12.2 1.0
C H:GLY193 4.0 10.4 1.0
CA H:CYS191 4.1 12.9 1.0
CB H:ASP194 4.1 9.8 1.0
O H:HOH1207 4.1 20.1 1.0
O H:HOH1261 4.4 20.2 1.0
C15 H:QQT1001 4.4 11.9 1.0
N H:CYS191 4.4 11.4 1.0
CB H:GLU192 4.4 18.9 1.0
O H:GLU192 4.5 15.7 1.0
C19 H:QQT1001 4.6 13.4 1.0
O9 H:QQT1001 4.7 16.0 1.0
N11 H:QQT1001 4.9 14.8 1.0
CG H:GLU192 4.9 25.1 1.0
O H:ASP194 5.0 8.6 1.0

Reference:

A.Hillisch, K.M.Gericke, S.Allerheiligen, S.Roehrig, M.Schaefer, A.Tersteegen, S.Schulz, P.Lienau, M.Gnoth, V.Puetter, R.C.Hillig, S.Heitmeier. Design, Synthesis, and Pharmacological Characterization of A Neutral, Non-Prodrug Thrombin Inhibitor with Good Oral Pharmacokinetics. J.Med.Chem. V. 63 12574 2020.
ISSN: ISSN 0022-2623
PubMed: 33108181
DOI: 10.1021/ACS.JMEDCHEM.0C01035
Page generated: Fri Aug 2 05:26:25 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy